Caldwell Trust’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.7K | Hold |
660
|
|
||||
|
2025
Q1 | $53.5K | Hold |
660
|
|
||||
|
2024
Q4 | $59.4K | Hold |
660
|
|
||||
|
2024
Q3 | $65.2K | Hold |
660
|
|
||||
|
2024
Q2 | $61.2K | Sell |
660
-55
|
|
||||
|
2024
Q1 | $67.8K | Hold |
715
|
|
||||
|
2023
Q4 | $63.8K | Sell |
715
-405
|
|
||||
|
2023
Q3 | $81.8K | Hold |
1,120
|
|
||||
|
2023
Q2 | $93.2K | Hold |
1,120
|
|
||||
|
2023
Q1 | $85.4K | Hold |
1,120
|
|
||||
|
2022
Q4 | $93K | Sell |
1,120
-150
|
|
||||
|
2022
Q3 | $101K | Sell |
1,270
-20
|
|
||||
|
2022
Q2 | $95.8K | Hold |
1,290
|
|
||||
|
2022
Q1 | $116K | Sell |
1,290
-100
|
|
||||
|
2021
Q4 | $156K | Hold |
1,390
|
|
||||
|
2021
Q3 | $175K | Sell |
1,390
-150
|
|
||||
|
2021
Q2 | $209K | Buy |
1,540
+20
|
|
||||
|
2021
Q1 | $206K | Hold |
1,520
|
|
||||
|
2020
Q4 | $214K | Hold |
1,520
|
|
||||
|
2020
Q3 | $169K | Buy |
1,520
+160
|
|
||||
|
2020
Q2 | $152K | Buy |
1,360
+20
|
|
||||
|
2020
Q1 | $104K | Buy |
1,340
+300
|
|
||||
|
2019
Q4 | $98.9K | Buy |
+1,040
|
|